Patients are increasingly turning to the internet in order to select their own treatments. Gemma O'Reilly considers the implications for pharma PROs whose ability to influence blog chat is limited by regulations.
To access this article and other content from the PRWeek.com archive, you must be a paid subscriber to PRWeek magazine. As a subscriber you also gain free access to all PRWeek's international titles and online services.
If you have a paid subscription to PRWeek magazine but have not used PRWeek.com before, please click here to activate your subscription
Copyright © 2005 PRWeek
